Literature DB >> 19629524

Immunohistological studies on Onchocerca volvulus paramyosin.

Klaus D Erttmann1, Dietrich W Büttner.   

Abstract

Paramyosin is a muscular protein exclusively found in invertebrate species, which has been proposed as a vaccine candidate against infections with Schistosoma mansoni and Brugia malayi. Here, we report the studies on the distribution of Onchocerca volvulus paramyosin, designated OvPmy, in different O. volvulus stages by immunohistochemistry using rabbit antibodies raised against the recombinant OvPmy protein as well as the induction of the human humoral immune response to OvPmy. To conduct the studies, OvPmy was expressed in Escherichia coli as a fusion protein to raise the rabbit antibodies. The recombinant OvPmy was tested in immunoblots using sera from individuals living in an area hyperendemic for onchocerciasis in Liberia, West Africa. The antibodies used here localised paramyosin exclusively in the muscle tissue of O. volvulus as well as Onchocerca ochengi. No extracellular compartments, such as the cuticle or the lumina of the pseudocoeloma cavity, were labelled; however, labelling was seen in microfilarial fragments taken up by host immune cells, such as giant cells. It was recognised by anti-paramyosin antibodies of a group of onchocerciasis patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629524     DOI: 10.1007/s00436-009-1566-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  19 in total

1.  The Role of Microscopy in the Investigation of Paramyosin as a Vaccine Candidate against Schistosoma japonicum.

Authors:  G N Gobert
Journal:  Parasitol Today       Date:  1998-03

2.  Molecular cloning and pre-mRNA maturation of Onchocerca volvulus paramyosin.

Authors:  A Dahmen; M Gallin; M Schumacher; K D Erttmann
Journal:  Mol Biochem Parasitol       Date:  1993-02       Impact factor: 1.759

3.  Schistosoma japonicum: immunolocalization of paramyosin during development.

Authors:  G N Gobert; D J Stenzel; M K Jones; D E Allen; D P McManus
Journal:  Parasitology       Date:  1997-01       Impact factor: 3.234

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Immunohistological studies on macrophages in lymph nodes of onchocerciasis patients after treatment with ivermectin.

Authors:  J Knab; K Darge; D W Büttner
Journal:  Trop Med Int Health       Date:  1997-12       Impact factor: 2.622

7.  Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

Authors:  E J Pearce; S L James; S Hieny; D E Lanar; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Molecular cloning of an alpha-enolase from the human filarial parasite Onchocerca volvulus that binds human plasminogen.

Authors:  Abbas Jolodar; Peter Fischer; Simone Bergmann; Dietrich W Büttner; Sven Hammerschmidt; Norbert W Brattig
Journal:  Biochim Biophys Acta       Date:  2003-06-19

9.  The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4.

Authors:  Norbert W Brattig; Chiara Bazzocchi; Carsten J Kirschning; Norbert Reiling; Dietrich W Büttner; Fabrizio Ceciliani; Frank Geisinger; Hubertus Hochrein; Martin Ernst; Hermann Wagner; Claudio Bandi; Achim Hoerauf
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  River blindness: a success story under threat?

Authors:  María-Gloria Basáñez; Sébastien D S Pion; Thomas S Churcher; Lutz P Breitling; Mark P Little; Michel Boussinesq
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.